Search
Close this search box.

Author name: Sandra Galvin

Discover the Future of PPI in Trials Methodology: Your Invitation to Explore “A Sense of Elsewhere”

Discover the Future of Clinical Trials: Your Invitation to Explore “A Sense of Elsewhere“   Discover our practical plan for enhancing patient and public involvement (PPI) in clinical trials, led by Prof. Derek Stewart and inspired by Colm Tóibín’s reflections on Wexford. This roadmap outlines our approach for the coming year to improve the quality […]

Discover the Future of PPI in Trials Methodology: Your Invitation to Explore “A Sense of Elsewhere” Read More »

Beyond the Trial: Fulfilling Participant Expectations with Transparent Results Sharing in the MIAMI Hypertension Trial

University of Galway trial team collaborates with participants for priority sharing of clinical trial insights. The MIAMI pilot cluster RCT, aimed at enhancing adherence to antihypertensive medication, recently culminated in a unique gathering at Croí, Galway, which was shaped significantly by patient insights. This initiative, sparked by recommendations from the MIAMI trial Public and Patient

Beyond the Trial: Fulfilling Participant Expectations with Transparent Results Sharing in the MIAMI Hypertension Trial Read More »

Revolutionising Clinical Trials: Introducing the TMRN-TMRP Communication Wheel for Enhanced Stakeholder Engagement

The Trial Conduct Working Group of the Trials Methodology Research Partnership established a working group in 2020 to advance the research agenda on best practices for communicating with stakeholders across the clinical trial lifecycle. Through an iterative process, the group developed the TMRN-TMRP Communication Wheel, a visual aid identifying key groups of stakeholders and when

Revolutionising Clinical Trials: Introducing the TMRN-TMRP Communication Wheel for Enhanced Stakeholder Engagement Read More »

Diversity in Clinical Trials: Insights from the International PPI Network Webinar

In healthcare research, randomised trials are a cornerstone for advancing medical knowledge and treatment. However, a critical issue that often goes unnoticed is the lack of diversity in these trials. Many people, particularly from varied ethnic groups who might benefit the most from improved treatments, find themselves underrepresented. Addressing this gap, the International Patient and

Diversity in Clinical Trials: Insights from the International PPI Network Webinar Read More »

Join the working groups

Looking for Trials Methodology research inspiration and collaboration? Join the working groups.

The HRB-TMRN is a proud Partner in the MRC-NIHR-Trials Methodology Research Partnership in the UK. This Partnership offers significant opportunity for trials methodology Researchers to develop and expand their collaborative personal networks. There are eight TMRP working groups which each specialise in specific areas relevant to trial methodology, with many active sub-groups. The main thematic

Looking for Trials Methodology research inspiration and collaboration? Join the working groups. Read More »

Placement Scheme

Trial Governance Placement Scheme launch: March 2023

The Centre for Trials Research (CTR), Cardiff University is delighted to be working in partnership with the Health Research Board -Trials Methodology Research Network (HRB-TMRN) in Ireland, to launch the new Trial Governance Placement Scheme from March 2023. This is a fantastic opportunity for the CTR to forge a collaboration with international colleagues and to share

Trial Governance Placement Scheme launch: March 2023 Read More »

Involving patients

Need to do better at involving patients and public in trial outcome selection

Written by Prof Shaun Treweek – Trial Forge, University of Aberdeen In 2022 we published an article called ‘Getting it wrong most of the time? Comparing trialists’ choice of primary outcome with what patients and health professionals want‘.  It looked at the outcomes selected in 44 breast cancer and kidney trials and asked patients and

Need to do better at involving patients and public in trial outcome selection Read More »

HRB-TMRN Research Associate secures HRB funding to nurture and develop trials methodology research agenda

HRB invests €7 million to nurture a talented new generation of academic researchers Health inequality, schizophrenia, and therapies in children with cystic fibrosis are three of nine important topics to be addressed by our Emerging Investigator Awards for Health (EIA) 2022. Dr Karen Matvienko-Sikar based in UCC and a HRB-TMRN Research Associate secured funding for

HRB-TMRN Research Associate secures HRB funding to nurture and develop trials methodology research agenda Read More »